NCT00385658
- Conditions
- Dyslipidemia, Dyslipidemias, Glucose Metabolism Disorders, +6 more
- Locations
-
- Investigative Centers, Germany
- Novartis Pharma AG Basel, Switzerland
Clinical trial condition
Explore clinical trials studying Insulin Resistance. Study availability and eligibility vary by location and protocol.
NCT00385658
NCT00561626
NCT00394745
NCT01790724
NCT00138528
NCT02379559
NCT00422396
NCT00966407
NCT00852475
NCT03036332
Not specified